Research projects

Granted by ISCIII COVID-19 funds and other projects adhered to the ISCIII-COVID-19 Registry

The ISCIII granted research projects with the COVID-19 extraordinary fund to promote knowledge about SARS-CoV-2 and COVID-19 disease as well as its impact on infected people, with the aim of contributing to efficient patient treatment and/or public health preparedness and response. The expected impact is to:

The table will be updated with additional data regarding outcomes as they are supplied by ISCIII.

Last update: 2021-09-24
Organisation
Unicentric
Multicentric
Clinical Trial
Yes
No
Topic call
Artificial intelligence
COVID-19 disease characterization
Diagnostics
Epidemiological surveillance
SARS-CoV-2 characterization
Socio-economic impact
Therapies
Vaccines
Download as CSV
Project Ref. ID Center Trial Organisation Topic call
Clinical-epidemiological study of coronavirus disease (COVID-19) in health centers: COVID-A study
Pedro Abizanda Soler
Servicio de Salud de Castilla-La Mancha (SESCAM)
Organization: Multicentric
Clinical trial: No
Topic call: Epidemiological surveillance, Socio-economic impact
COV20/00004 Servicio de Salud de Castilla-La Mancha (SESCAM) No Multicentric Epidemiological surveillance, Socio-economic impact
Pilot study to evaluate the efficacy and safety of mefloquine as prophylaxis in people exposed to the disease caused by the SARS-CoV-2 coronavirus (COVID-19) (MEFLOCOVID-19)
Félix Gutiérrez Rodero
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (Fisabio)
Organization: Multicentric
Clinical trial: Yes
Topic call: Therapies
COV20/00005 Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (Fisabio) Yes Multicentric Therapies
Epidemiological record of pregnant women with COVID-19.
Óscar Martínez Pérez
Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana
Organization: Multicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/00021 Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana No Multicentric Epidemiological surveillance
Randomized clinical trial to evaluate the efficacy of different treatments in patients with COVID-19 who require hospitalization (PanCOVID19)
José Ramón Arribas
Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid
Organization: Multicentric
Clinical trial: Yes
Topic call: Therapies
COV20/00023 Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid Yes Multicentric Therapies
Use of drugs that increase the expression of ACE2 and the risk of COVID-19: A case-population study
Francisco José de Abajo Iglesias
Fundación para la Investigación Biomédica del Hospital Universitario Príncipe de Asturias (HUPA)
Organization: Unicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/00027 Fundación para la Investigación Biomédica del Hospital Universitario Príncipe de Asturias (HUPA) No Unicentric Epidemiological surveillance
Short, medium and long-term effect of COVID-19 disease on the cardiovascular system.
Salvatore Brugaletta
Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS)
Organization: Unicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/00040 Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS) No Unicentric Epidemiological surveillance
Therapeutic repositioning directed at inhibition of ACE2 expression and viral S-trimer proteolysis
Manuel Portero-Otin
Instituto de Investigación Biomédica de Lleida-Fundación Dr Pifarre (IRB Lleida)
Organization: Unicentric
Clinical trial: No
Topic call: Therapies
COV20/00047 Instituto de Investigación Biomédica de Lleida-Fundación Dr Pifarre (IRB Lleida) No Unicentric Therapies
Development of a vaccine against SARS-VOC-2 by means of muNS-Mi micro / nanospheres
José M. Martínez Costas
Universidad de Santiago de Compostela (USC)
Organization: Multicentric
Clinical trial: No
Topic call: Vaccines
COV20/00050 Universidad de Santiago de Compostela (USC) No Multicentric Vaccines
Identification of Mpro protease inhibitors of the COVID-19 virus by drug repositioning
Juan Jesus Perez Gonzalez
Universidad Politécnica de Cataluña (UPC)
Organization: Unicentric
Clinical trial: No
Topic call: Therapies
COV20/00052 Universidad Politécnica de Cataluña (UPC) No Unicentric Therapies
Evaluation of epidemiological scenarios of COVID19 disease through an original model using membrane computing
Fernando Baquero
Fundación de Investigación Biomédica del Hospital Ramón y Cajal (IRYCIS)
Organization: Unicentric
Clinical trial: No
Topic call: Artificial intelligence
COV20/00067 Fundación de Investigación Biomédica del Hospital Ramón y Cajal (IRYCIS) No Unicentric Artificial intelligence
Pilot, randomized, multicenter, open-label clinical trial of combined use of hydroxychloroquine, azithromycin, and tocilizumab for the treatment of SARS-CoV-2 infection (COVID-19) (TCOVID)
Pere Domingo Pedrol
Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau (IIB Sant Pau)
Organization: Multicentric
Clinical trial: Yes
Topic call: Therapies
COV20/00070 Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau (IIB Sant Pau) Yes Multicentric Therapies
Multi-center, Randomized Clinical Trial of Convalescent Plasma Therapy Versus Standard of Care for the Treatment of COVID-19 in Hospitalized Patients (ConPlas-19)
Cristina Avendaño Solá & Rafael Duarte Palomino
Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana
Organization: Multicentric
Clinical trial: Yes
Topic call: Therapies
COV20/00072 Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana Yes Multicentric Therapies
Proof of Concept of fast detection method of SARS-CoV-2 contaminated surfaces using multispectral holographic and optical analysis with artificial intelligence.
Emilio Gómez González
Universidad de Sevilla (US)
Organization: Unicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/00080 Universidad de Sevilla (US) No Unicentric Epidemiological surveillance
PsyCorona: a multinational initiative of urgent data collection with a longitudinal and prospective approach
Manuel Moyano Pacheco
Universidad de Córdoba (UC)
Organization: Multicentric
Clinical trial: No
Topic call: Socio-economic impact
COV20/00086 Universidad de Córdoba (UC) No Multicentric Socio-economic impact
Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection (SEVO-COVID19)
Rafael Badenes Quilés
Instituto de Investigación Sanitaria del Hospital Clínico de Valencia (INCLIVA)
Organization: Multicentric
Clinical trial: Yes
Topic call: Therapies
COV20/00096 Instituto de Investigación Sanitaria del Hospital Clínico de Valencia (INCLIVA) Yes Multicentric Therapies
COVID-19 infection in HIV-infected patients included in CoRIS
Juan Berenguer
Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00108 Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) No Multicentric COVID-19 disease characterization
Risk factors, personalized prognosis and one-year follow-up of patients admitted to the Spanish Intensive Care Units infected with the SARS-CoV-2 virus (CIBERSESUCICOVID)
Antoni Torre Martí
Centro de Investigación Biomédica en Red, CIBER (Hospital Clinic, Barcelona)
Organization: Multicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/00110 Centro de Investigación Biomédica en Red, CIBER (Hospital Clinic, Barcelona) No Multicentric Epidemiological surveillance
Real-time quantification of new unreported cases of COVID-19 in Spain
David Moriña Soler
Consorci Centre de Recerca Matematica (CRM)
Organization: Unicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/00115 Consorci Centre de Recerca Matematica (CRM) No Unicentric Epidemiological surveillance
Identification of the dynamic transcriptomic profile in patients with COVID-19 and acute respiratory distress syndrome (TRANSCOVID)
Jordi Carratalà Fernández
Fundación del Instituto de Investigación Biomédica de Bellvitge (Fundación IDIBELL)
Organization: Unicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00121 Fundación del Instituto de Investigación Biomédica de Bellvitge (Fundación IDIBELL) No Unicentric COVID-19 disease characterization
Development of colorimetric sensors based on gold nanoparticles for the detection of SARS-COV-2 (NANO COVID-19)
Rodolfo Miranda Soriano
Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA)
Organization: Unicentric
Clinical trial: No
Topic call: Diagnostics
COV20/00122 Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA) No Unicentric Diagnostics
Addressing unknowns of COVID-19 transmission and infection combining pathogen genomics and epidemiology to inform public health interventions
Iñaki Comas Espadas
Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC)
Organization: Multicentric
Clinical trial: No
Topic call: Epidemiological surveillance, Artificial intelligence, Therapies, SARS-CoV-2 characterization
COV20/00140 Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC) No Multicentric Epidemiological surveillance, Artificial intelligence, Therapies, SARS-CoV-2 characterization
SARS-CoV2 Airbone Transmission: Innovative Technologies for virus detection in hospitals
Antonio Alcamí Pertejo
Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC)
Organization: Unicentric
Clinical trial: No
Topic call: Diagnostics
COV20/00144 Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC) No Unicentric Diagnostics
Development of a vaccine, MVA-COVID-19, expressing SARS-CoV-2 antigens
Juan García Arriaza
Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC)
Organization: Unicentric
Clinical trial: No
Topic call: Vaccines
COV20/00151 Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC) No Unicentric Vaccines
Early diagnosis of COVID-19 by isolation of exosomes in individuals suspected of the disease
Mª del Pilar Martín Duque
Instituto Aragonés de Ciencias de la Salud (IACS)
Organization: Unicentric
Clinical trial: No
Topic call: Diagnostics
COV20/00155 Instituto Aragonés de Ciencias de la Salud (IACS) No Unicentric Diagnostics
NGS Analysis of the SARS-CoV2 outbreak at the Elche General Hospital
Antonio Galiana Cabrera
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (Fisabio)
Organization: Unicentric
Clinical trial: No
Topic call: SARS-CoV-2 characterization
COV20/00156 Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (Fisabio) No Unicentric SARS-CoV-2 characterization
The neurological component of COVID-19. Does the Neuro-COVID-19 exist?
Pedro Jesus Serrano Castro / Fernando Rodriguez de Fonseca
Fundación para la investigación de Málaga en Biomedicina y Salud (FIMABIS)
Organization: Unicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00157 Fundación para la investigación de Málaga en Biomedicina y Salud (FIMABIS) No Unicentric COVID-19 disease characterization
Search for immunological, prognostic and therapeutic markers in patients with COVID-19
Marcos López Hoyos
Instituto de investigación sanitaria Valdecilla (IDIVAL)
Organization: Unicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00170 Instituto de investigación sanitaria Valdecilla (IDIVAL) No Unicentric COVID-19 disease characterization
Nanosensor-based diagnosis and rapid solution identification of SARS-COV-2 virus interaction with its cellular receptor (NANOCOMPETE)
Francisco García Cózar
Instituto de Investigación e Innovación Biomédica de Cádiz (INIBICA)
Organization: Unicentric
Clinical trial: No
Topic call: Diagnostics
COV20/00173 Instituto de Investigación e Innovación Biomédica de Cádiz (INIBICA) No Unicentric Diagnostics
STOP-Coronavirus: clinical, immunological, genomic, virological and bioethical factors of COVID-19
José María Aguado García
Instituto de Investigación Hospital 12 de Octubre (imas12)
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00181 Instituto de Investigación Hospital 12 de Octubre (imas12) No Multicentric COVID-19 disease characterization
An innovative therapy against Covid-19 based on circular RNAs
Juana Díez Antón
Universidad Pompeu Fabra (UPF)
Organization: Unicentric
Clinical trial: No
Topic call: Therapies
COV20/00183 Universidad Pompeu Fabra (UPF) No Unicentric Therapies
Gestation and COVID-19: clinical and microbiological study (GESTA-COVID19)
Anna Suy Franch
Fundación del Instituto de Investigación Vall d'Hebron (VHIR)
Organization: Multicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/00188 Fundación del Instituto de Investigación Vall d'Hebron (VHIR) No Multicentric Epidemiological surveillance
Study of the immune response in nested cases in a cohort to assess the effect of antiretrovirals on the progression of SARS-CoV-2 coronavirus infection
Carolina Cubillos Zapata
Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid
Organization: Unicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00207 Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid No Unicentric COVID-19 disease characterization
Determination of the presence of SARS-CoV-2 in environmental samples and its potential indirect transmission
Pilar Domingo Calap
Universidad de Valencia (UV)
Organization: Multicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/00210 Universidad de Valencia (UV) No Multicentric Epidemiological surveillance
Study to identify cytokine profiles capable of predicting the development of ARDS
Jesus Garcia-Donas Jimenez
Fundación de Investigación HM Hospitales
Organization: Multicentric
Clinical trial: No
Topic call: Diagnostics
COV20/00211 Fundación de Investigación HM Hospitales No Multicentric Diagnostics
Preclinical development of innovative mRNA/MVAvaccines against SARS-CoV2
Felipe García
Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS)
Organization: Unicentric
Clinical trial: No
Topic call: Vaccines
COV20/00214 Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS) No Unicentric Vaccines
SARS-CoV-2 infection in patients with Inflammatory bowel disease (COVID-19-EII)
Maria Esteve y Yamile Zabana
Fundació Docència i Recerca Mutua Terrassa
Organization: Multicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/00227 Fundació Docència i Recerca Mutua Terrassa No Multicentric Epidemiological surveillance
Study of the Microbiome and Virome associated with COVID-19
Juan Carlos Rodríguez Díaz
Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL)
Organization: Unicentric
Clinical trial: No
Topic call: Epidemiological surveillance, COVID-19 disease characterization
COV20/00236 Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL) No Unicentric Epidemiological surveillance, COVID-19 disease characterization
SARS-CoV-2 biosecurity vaccine development platforms
David Escors Murugarren
Fundación Miguel Servet (Navarrabiomed)
Organization: Unicentric
Clinical trial: No
Topic call: Vaccines
COV20/00237 Fundación Miguel Servet (Navarrabiomed) No Unicentric Vaccines
ACE2-ORG: Development of a human cellular platform unveiling Angiotensin-converting enzyme 2 (ACE2)-SARS-CoV-2 interactions
Nuria Montserrat Pulido
Fundación del Instituto de Bioingeniería de Cataluña (IBEC)
Organization: Unicentric
Clinical trial: No
Topic call: SARS-CoV-2 characterization
COV20/00278 Fundación del Instituto de Bioingeniería de Cataluña (IBEC) No Unicentric SARS-CoV-2 characterization
Quick Detection and Characterization of COVID-19 on the patient
Felipe J. Chaves Martínez
Instituto de Investigación Sanitaria del Hospital Clínico de Valencia (INCLIVA)
Organization: Multicentric
Clinical trial: No
Topic call: Diagnostics, COVID-19 disease characterization
COV20/00279 Instituto de Investigación Sanitaria del Hospital Clínico de Valencia (INCLIVA) No Multicentric Diagnostics, COVID-19 disease characterization
Hydroxychloroquine efficacy in preventing SARS-CoV-2 infection and CoVid-19 disease severity during pregnancy (COVID-PREG)
Clara Menéndez Santos
Fundación Privada del Instituto de Salud Global de Barcelona (ISGlobal)
Organization: Multicentric
Clinical trial: Yes
Topic call: Therapies
COV20/00286 Fundación Privada del Instituto de Salud Global de Barcelona (ISGlobal) Yes Multicentric Therapies
An Efficient Peptide Vector for mRNA Vaccination Against COVID19
Javier Montenegro García
Universidad de Santiago de Compostela (USC)
Organization: Unicentric
Clinical trial: No
Topic call: Vaccines
COV20/00297 Universidad de Santiago de Compostela (USC) No Unicentric Vaccines
Analysis of soluble markers of immune activation and CD8 NK and T cell populations in patients with SARS-CoV-2 infection
Julián Pardo, José Ramón Paño Pardo
Instituto de Investigación Sanitaria de Aragón (IISA)
Organization: Unicentric
Clinical trial: No
Topic call: COVID-19 disease characterization, SARS-CoV-2 characterization
COV20/00308 Instituto de Investigación Sanitaria de Aragón (IISA) No Unicentric COVID-19 disease characterization, SARS-CoV-2 characterization
Ultrasound monitoring in pregnant women with COVID-19 infection. Risks associated with severe infection and the trimester of pregnancy.
Marta López Rojano
Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS)
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00310 Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS) No Multicentric COVID-19 disease characterization
Immunosenescence as a risk factor for SARS-CoV-2 infection
David Otaegui / Alvaro Prada
Instituto de Investigación Sanitaria Biodonostia (IIS Biodonostia)
Organization: Unicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00314 Instituto de Investigación Sanitaria Biodonostia (IIS Biodonostia) No Unicentric COVID-19 disease characterization
Functional characterization of SARS-CoV-2-specific T and B cell long-lasting Immunity in immunocompetent and immunosuppressed patients developing SARS-CoV-2 infection (COV-Immunity)
Oriol Bestard Matamoros
Instituto de Investigación Biomédica de Bellvitge (IDIBELL)
Organization: Unicentric
Clinical trial: No
Topic call: SARS-CoV-2 characterization
COV20/00324 Instituto de Investigación Biomédica de Bellvitge (IDIBELL) No Unicentric SARS-CoV-2 characterization
Exploiting protective immune responses to COVID-19 to unravel mechanisms associated with favorable clinical outcomes (PROTECTIVE STUDY)
Sergio Serrano-Villar
Fundación de Investigación Biomédica del Hospital Ramón y Cajal (IRYCIS)
Organization: Unicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00349 Fundación de Investigación Biomédica del Hospital Ramón y Cajal (IRYCIS) No Unicentric COVID-19 disease characterization
COVID-9 prevalence in patients with chronic inflammatory arthritis under treatment
Sara Marsal Barril
Fundación del Instituto de Investigación Vall d'Hebron (VHIR)
Organization: Unicentric
Clinical trial: No
Topic call: Therapies, Epidemiological surveillance
COV20/00357 Fundación del Instituto de Investigación Vall d'Hebron (VHIR) No Unicentric Therapies, Epidemiological surveillance
Multicenter study of coronavirus disease 2019 (COVID-2019) in Solid Organ Transplant Recipients
Maria Elisa Cordero Matia
Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI)
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00370 Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI) No Multicentric COVID-19 disease characterization
SARS-CoV-2 Inhibition, Host Selection and Next-Move Prediction Through High-Performance Computing.
Modesto Orozco
Fundación del Institut de Recerca Biomédica (IRB Barcelona)
Organization: Unicentric
Clinical trial: No
Topic call: Therapies, SARS-CoV-2 characterization, Epidemiological surveillance
COV20/00373 Fundación del Institut de Recerca Biomédica (IRB Barcelona) No Unicentric Therapies, SARS-CoV-2 characterization, Epidemiological surveillance
Role of NK cells in susceptibility and prognosis of SARS-CoV2 infection (COVID-19)
Enrique Bernal Morell
Fundación para la Formación e Investigación Sanitarias de la Región de Murcia (FFIS)
Organization: Unicentric
Clinical trial: No
Topic call: SARS-CoV-2 characterization
COV20/00377 Fundación para la Formación e Investigación Sanitarias de la Región de Murcia (FFIS) No Unicentric SARS-CoV-2 characterization
Derivation and validation of a prognostic scale in COVID-19 pneumonia. National multicenter study.
Rosario Menéndez Villanueva
Instituto de Investigación Sanitaria La Fe (IIS La Fe)
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization, Artificial intelligence
COV20/00385 Instituto de Investigación Sanitaria La Fe (IIS La Fe) No Multicentric COVID-19 disease characterization, Artificial intelligence
Impact of monoclonal B-lymphocytosis and the state of the immune system on the development and evolution of COVID-19 infection in adults
José Alberto Orfao de Matos Correia e Vale
Instituto de Investigación Biomédica de Salamanca (IECSCYL-IBSAL)
Organization: Unicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00386 Instituto de Investigación Biomédica de Salamanca (IECSCYL-IBSAL) No Unicentric COVID-19 disease characterization
COVID-19, immunological risk profile (attached to the project presented by VHIR IP R Pujol-Borrell)
Aina Teniente Serra
Fundación del Instituto de Investigación Germans Trias I Pujol (IGTP)
Organization: Multicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/00388 Fundación del Instituto de Investigación Germans Trias I Pujol (IGTP) No Multicentric Epidemiological surveillance
A prospective, multicenter, randomized, parallel, double-blind, placebo-controlled phase IIb clinical trial to evaluate intravenous infusion of Defibrotide in the prevention and treatment of respiratory distress and cytokine release syndrome in patients with COVID-19. (DEFACOVID)
Jose M. Moraleda Jiménez
Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB)
Organization: Multicentric
Clinical trial: Yes
Topic call: Therapies
COV20/00399 Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB) Yes Multicentric Therapies
Residual pulmonary fibrosis and lung capacity in survivors of SARS-CoV-2
José Ramón Blanco Ramos
Fundación Rioja Salud
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00401 Fundación Rioja Salud No Multicentric COVID-19 disease characterization
Prognosis of patients infected with the new SARS-CoV-2 coronavirus
Francisco Gude Sampedro
Fundación del Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00404 Fundación del Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) No Multicentric COVID-19 disease characterization
COVID-19, immune risk profile (attached to 00654 project)
Ricardo Pujol Borrell
Fundación del Instituto de Investigación Vall d'Hebron (VHIR)
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00416 Fundación del Instituto de Investigación Vall d'Hebron (VHIR) No Multicentric COVID-19 disease characterization
COVID-19 in patients with heart failure and family heart disease
Juan Ramón Gimeno Blanes
Fundación para la formación e investigación sanitarias de la región de Murcia (FFIS)
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization, Epidemiological surveillance, Artificial intelligence
COV20/00420 Fundación para la formación e investigación sanitarias de la región de Murcia (FFIS) No Multicentric COVID-19 disease characterization, Epidemiological surveillance, Artificial intelligence
Epidemiological study and clinical-molecular implications of angiotensin in the prognosis of SARS-Cov-2 infection
Maria Sonia Gaztambide Saénz
Instituto de Investigación Sanitaria Biocruces Bizkaia (IIS Biocruces)
Organization: Unicentric
Clinical trial: No
Topic call: COVID-19 disease characterization, Epidemiological surveillance, Artificial intelligence
COV20/00421 Instituto de Investigación Sanitaria Biocruces Bizkaia (IIS Biocruces) No Unicentric COVID-19 disease characterization, Epidemiological surveillance, Artificial intelligence
Interaction between SARS-CoV-2 and the human respiratory epithelium: sequestration of endocytosis and exocytosis pathways
José María Carvajal González
Universidad de Extremadura
Organization: Unicentric
Clinical trial: No
Topic call: SARS-CoV-2 characterization
COV20/00429 Universidad de Extremadura No Unicentric SARS-CoV-2 characterization
Decoy-ACE2: Use of catalytically inactivated soluble ACE2 as an anti-COVID-19 drug.
Alberto Marina Moreno / Vicente Rubio Zamora
Centro de Investigación Biomédica en Red, CIBER (Hospital Clinic, Barcelona)
Organization: Multicentric
Clinical trial: No
Topic call: Therapies
COV20/00437 Centro de Investigación Biomédica en Red, CIBER (Hospital Clinic, Barcelona) No Multicentric Therapies
Clinical characterization of COVID-19 infection: Prognostic stratification and complications
Susana García Gutiérrez
Asociación del Instituto de Investigación en Servicios de Salud-Kronikgune
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization, Epidemiological surveillance, Artificial intelligence
COV20/00459 Asociación del Instituto de Investigación en Servicios de Salud-Kronikgune No Multicentric COVID-19 disease characterization, Epidemiological surveillance, Artificial intelligence
Effect of drug consumption before and during SARS-COV-2 infection on the evolution of patients with COVID-19. A population-based cohort study
Adolfo Figueiras Guzmán
Fundación del Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
Organization: Multicentric
Clinical trial: No
Topic call: Artificial intelligence
COV20/00470 Fundación del Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) No Multicentric Artificial intelligence
Evolution of the inflammatory profile and redox status in COVID-19 patients: Possible therapeutic targets?
Eduardo Tamayo Gómez
Hospital Clínico Universitario de Valladolid (HCU Valladolid)
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization, Therapies
COV20/00491 Hospital Clínico Universitario de Valladolid (HCU Valladolid) No Multicentric COVID-19 disease characterization, Therapies
Antiviral design for SARS based on polypharmacology
Victor Guallar
Barcelona Supercomputing Centre (BSC)
Organization: Unicentric
Clinical trial: No
Topic call: Therapies
COV20/00505 Barcelona Supercomputing Centre (BSC) No Unicentric Therapies
Evaluation of the Specific Immune Response to SARS-CoV-2
Ramón Gimeno Martínez
Fundación del Institut Mar d'Investigacions Médiques (FIMIM)
Organization: Unicentric
Clinical trial: No
Topic call: Therapies
COV20/00508 Fundación del Institut Mar d'Investigacions Médiques (FIMIM) No Unicentric Therapies
Prognostic variables. Consumed resources and hospital cost of patients entered by SARS-CoV-2 infection, according to their fragility
Eva María Andrés Esteban
Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid
Organization: Unicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/00519 Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid No Unicentric Epidemiological surveillance
Retrospective cohort study to assess the effect of NSAIDs and ACE inhibitors on the prognosis of symptomatic patients with COVID-19
Raquel Cobos Campos
Asociación del Instituto de Investigación Sanitaria Bioaraba
Organization: Unicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/00527 Asociación del Instituto de Investigación Sanitaria Bioaraba No Unicentric Epidemiological surveillance
Pre-clinical mouse models for the study of COVID-19 and trial of therapeutic strategies
Sagrario Ortega Jiménez
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (CNIO)
Organization: Unicentric
Clinical trial: No
Topic call: Therapies, Vaccines
COV20/00532 Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (CNIO) No Unicentric Therapies, Vaccines
Infection, hospitalization, ICU admission, and death from SARS-CoV-2 in a population cohort
Jesus Castilla Catalán
Fundación del Instituto de Investigación Sanitaria de Navarra (IdiSNA)
Organization: Multicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/00542 Fundación del Instituto de Investigación Sanitaria de Navarra (IdiSNA) No Multicentric Epidemiological surveillance
Prevention of COVID19 infection by administering hydroxichlorochine in elderly institutionalised people and residential care staff. Controlled, open and randomized clinical trial (stepped-wedge) by clusters
José Miguel Morales Asensio
Fundación para la investigación de Málaga en Biomedicina y Salud (FIMABIS)
Organization: Multicentric
Clinical trial: Yes
Topic call: Therapies
COV20/00565 Fundación para la investigación de Málaga en Biomedicina y Salud (FIMABIS) Yes Multicentric Therapies
Deciphering ACE2-mediated SARS-CoV-2 lung infection
Carles Barceló Pascual
Fundación del Instituto de Investigación Sanitaria Illes Balears (IdISBa)
Organization: Unicentric
Clinical trial: No
Topic call: COVID-19 disease characterization, Therapies, SARS-CoV-2 characterization
COV20/00571 Fundación del Instituto de Investigación Sanitaria Illes Balears (IdISBa) No Unicentric COVID-19 disease characterization, Therapies, SARS-CoV-2 characterization
Study of the SARS-CoV-2 viral load in the respiratory tract and blood as a factor associated with the prognosis of COVID-19 in adults
Javier Sánchez Céspedes
Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI)
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00580 Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI) No Multicentric COVID-19 disease characterization
Elaboration of alert COVID-19 transmission maps in urban spaces oriented to the application of anti-propagation measures on a detailed scale
Mª Jesús Perles Roselló
Universidad de Málaga (UM)
Organization: Unicentric
Clinical trial: No
Topic call: Epidemiological surveillance, Socio-economic impact, Artificial intelligence
COV20/00587 Universidad de Málaga (UM) No Unicentric Epidemiological surveillance, Socio-economic impact, Artificial intelligence
Characterization and management of Post Intensive Care Syndrome in COVID-19 patients
Gonzalo Sol Fernández
Fundació Parc Taulí
Organization: Unicentric
Clinical trial: No
Topic call: COVID-19 disease characterization, Socio-economic impact
COV20/00595 Fundació Parc Taulí No Unicentric COVID-19 disease characterization, Socio-economic impact
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care (Solidarity)
Vicente Estrada & Antonio Portoles
Instituto de Investigación Sanitaria San Carlos (IdISSC)
Organization: Multicentric
Clinical trial: Yes
Topic call: Therapies
COV20/00612 Instituto de Investigación Sanitaria San Carlos (IdISSC) Yes Multicentric Therapies
Dynamic prediction of COVID-19 scenarios in the short and medium term (PREDICO)
Jorge Mira Perez
Universidad de Santiago de Compostela (USC)
Organization: Unicentric
Clinical trial: No
Topic call: Epidemiological surveillance, Socio-economic impact, Artificial intelligence
COV20/00617 Universidad de Santiago de Compostela (USC) No Unicentric Epidemiological surveillance, Socio-economic impact, Artificial intelligence
Genetic Determinants and Genomic Risk Biomarkers in Patients with SARS-COV-2 Coronavirus Infection
Angel Carracedo Alvarez (PI), Pablo Lapunzina (Co-PI)
Consorcio del Centro de Investigación Biomédica en Red MP (CIBER)
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00622 Consorcio del Centro de Investigación Biomédica en Red MP (CIBER) No Multicentric COVID-19 disease characterization
Design of molecular beacons for rapid and effective identification of SARS-CoV-2 RNA species in patient samples of COVID-19
Mario Fernández Fraga / Juan Ramón Tejedor Vaquero
Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC)
Organization: Unicentric
Clinical trial: No
Topic call: Diagnostics
COV20/00624 Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC) No Unicentric Diagnostics
Prognostic variables, resources consumed and cost in primary care of patients with COVID-19
Rosa Magallón Botaya
Instituto de Investigación Sanitaria de Aragón (IISA)
Organization: Unicentric
Clinical trial: No
Topic call: Epidemiological surveillance, Socio-economic impact
COV20/00634 Instituto de Investigación Sanitaria de Aragón (IISA) No Unicentric Epidemiological surveillance, Socio-economic impact
Treatment of patients with COVID-19 and non-severe pneumonia without hospital admission criteria: randomized clinical trial Protocol Code: COME-CLEAN EUDRACT 2020-001962-12
Carlos Guijarro Herraiz
Hospital Universitario Fundación Alcorcón
Organization: Multicentric
Clinical trial: Yes
Topic call: Therapies
COV20/00644 Hospital Universitario Fundación Alcorcón Yes Multicentric Therapies
Determinants of resistance and pathogenicity in SARS-CoV-2 infection: genomic and biochemical mechanisms
Carlos López Otín / Alejandro López Soto
Universidad de Oviedo
Organization: Unicentric
Clinical trial: No
Topic call: SARS-CoV-2 characterization
COV20/00652 Universidad de Oviedo No Unicentric SARS-CoV-2 characterization
COVID-19, immune risk profile (attached to 00416 project)
Jordi Bas Minguel
Fundación del Instituto de Investigación Biomédica de Bellvitge (Fundación IDIBELL)
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00654 Fundación del Instituto de Investigación Biomédica de Bellvitge (Fundación IDIBELL) No Multicentric COVID-19 disease characterization
Identification and characterization of the protective T-immune response to SARS-CoV-2: Guiding successful vaccine design
Julia Garcia Prado
Fundació IrsiCaixa
Organization: Unicentric
Clinical trial: No
Topic call: SARS-CoV-2 characterization
COV20/00660 Fundació IrsiCaixa No Unicentric SARS-CoV-2 characterization
Characterization and therapeutic management of immunological hyperactivation associated with mortality in COVID-19.
Rafael Correa Rocha
Instituto de Investigación Sanitaria Gregorio Marañón (IISGM)
Organization: Unicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00668 Instituto de Investigación Sanitaria Gregorio Marañón (IISGM) No Unicentric COVID-19 disease characterization
Registry of SARS-CoV-2 infection in patients with hemoglobinopathies and / or splenectomized: epidemiological surveillance and study of morbidity and mortality in risk groups.
Elena Cela de Julián
Instituto de Investigación Sanitaria Gregorio Marañón (IISGM)
Organization: Multicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/00675 Instituto de Investigación Sanitaria Gregorio Marañón (IISGM) No Multicentric Epidemiological surveillance
Creation of the COVID19 patient cohort and samples associated with the Biobank of the Instituto de Investigación Sanitaria Galicia Sur (IISGS)
Eva Poveda López
Fundación Biomédica Galicia Sur
Organization: Unicentric
Clinical trial: No
Topic call: COVID-19 disease characterization, Epidemiological surveillance
COV20/00698 Fundación Biomédica Galicia Sur No Unicentric COVID-19 disease characterization, Epidemiological surveillance
Use of ozone for the reuse of personal protective equipment (PPE). O3CoVid19PPE study
Bernardino Clavo Varas
Fundación del Instituto de Investigación Sanitaria de Canarias (FIISC)
Organization: Unicentric
Clinical trial: No
Topic call: Therapies, Socio-economic impact
COV20/00702 Fundación del Instituto de Investigación Sanitaria de Canarias (FIISC) No Unicentric Therapies, Socio-economic impact
MIND/COVID-19: Mental health Impact and NeeDs associated with COVID-19: a comprehensive national evaluation in Spain.
Jordi Alonso Caballero
Fundación del Instituto Mar de Investigaciones Médicas (FIMIM)
Organization: Multicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/00711 Fundación del Instituto Mar de Investigaciones Médicas (FIMIM) No Multicentric Epidemiological surveillance
Study of the dynamics of the SARS-CoV-2 epidemic with physical-mathematical epidemiological models. Monitoring, control strategies, simulations and surveys
Antonio Guirao Piñera
Universidad de Murcia
Organization: Unicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/00736 Universidad de Murcia No Unicentric Epidemiological surveillance
Design and development of peptide inhibitors of SARS CoV2 virus entry for human use
Bruno Sainz Anding
Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC)
Organization: Unicentric
Clinical trial: No
Topic call: Therapies
COV20/00749 Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC) No Unicentric Therapies
Radiographic screening, chest inspection in patients with COVID19
Francisco Javier Albiol Colomer
Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC)
Organization: Unicentric
Clinical trial: No
Topic call: Artificial intelligence
COV20/00750 Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC) No Unicentric Artificial intelligence
Short and medium term therapies for the treatment of COVID-19: senolytics and vaccine development
Cayetano Von Kobbe
Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC)
Organization: Unicentric
Clinical trial: No
Topic call: Therapies, Vaccines
COV20/00755 Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC) No Unicentric Therapies, Vaccines
Structural and Dynamic Characteristics of Intrinsically Disordered Proteins of the SARS-CoV-2 Virus
Douglas Vinson Laurents, Miguel Mompeán García
Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC)
Organization: Multicentric
Clinical trial: No
Topic call: SARS-CoV-2 characterization
COV20/00764 Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC) No Multicentric SARS-CoV-2 characterization
Mechanistic model based on artificial intelligence for the reuse of drugs against SARS-CoV-2 infection
Joaquín Dopazo Blázquez
Fundación Pública Andaluza Progreso y Salud
Organization: Unicentric
Clinical trial: No
Topic call: Therapies
COV20/00788 Fundación Pública Andaluza Progreso y Salud No Unicentric Therapies
Clinical utility of analysis of IL-6 signaling as an indicator of COVID-19 disease activity. Therapeutic opportunity with IL-6 trans-signaling blockers
Matilde Bustos de Abajo
Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC)
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00792 Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC) No Multicentric COVID-19 disease characterization
Clinical and immunovirological aspects of SARS-CoV2 infection in a cohort of pregnant women and newborns.
Maria Luisa Navarro Gómez
Instituto de Investigación Sanitaria Gregorio Marañón (IISGM)
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00808 Instituto de Investigación Sanitaria Gregorio Marañón (IISGM) No Multicentric COVID-19 disease characterization
Study of the protection of BCG and MTBVAC against SARS-COV-2 in primates
Carlos Martín Montañés
Universidad de Zaragoza
Organization: Unicentric
Clinical trial: No
Topic call: Vaccines
COV20/00820 Universidad de Zaragoza No Unicentric Vaccines
Rapid serological testing for combined detection of IgG and IgM against SARS-CoV-2
Ciara O`Sulivan
Universitat Rovira i Virgili
Organization: Multicentric
Clinical trial: No
Topic call: Diagnostics
COV20/00823 Universitat Rovira i Virgili No Multicentric Diagnostics
Incidence and characterization of low / high risk of complication profiles in people >60 years with COVID-19.
Ángel Vila Córcoles
IDIAP Jordi Gol
Organization: Unicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/00852 IDIAP Jordi Gol No Unicentric Epidemiological surveillance
Application of AI to the immediate prediction of time series to optimize resource management in epidemics
José Luis Aznarte Mellado
Universidad Nacional de Educación a Distancia (UNED)
Organization: Multicentric
Clinical trial: No
Topic call: Socio-economic impact, Artificial intelligence
COV20/00856 Universidad Nacional de Educación a Distancia (UNED) No Multicentric Socio-economic impact, Artificial intelligence
Dual Vaccinia MVA virus for immunization against SARS-CoV-2
Rafael Blasco Lozano
Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, O.A., M.P.
Organization: Unicentric
Clinical trial: No
Topic call: Vaccines
COV20/00901 Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, O.A., M.P. No Unicentric Vaccines
Seroprevalence against SARS-CoV-2 in pregnant women and newborns.
Javier Llorca Díaz / María Jesús Cabero Pérez
Instituto de Investigación Sanitaria Marqués de Valdecilla (IDIVAL)
Organization: Unicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/00923 Instituto de Investigación Sanitaria Marqués de Valdecilla (IDIVAL) No Unicentric Epidemiological surveillance
Regulation of macrophage extravasation by a2 adrenergic agonists in the STC associated with COVID-19
José Federico Díaz González
Fundación del Instituto de Investigación Sanitaria de Canarias (FIISC)
Organization: Unicentric
Clinical trial: No
Topic call: Therapies
COV20/00932 Fundación del Instituto de Investigación Sanitaria de Canarias (FIISC) No Unicentric Therapies
Medium and long-term forecast of the spread of COVID-19
David Expósito Singh
Universidad Carlos III
Organization: Multicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/00935 Universidad Carlos III No Multicentric Epidemiological surveillance
Immunological and virological factors in COVID-19 and their correlation with the evolution to severe forms of the disease.
Mercedes García Gasalla
Instituto de Investigación Sanitaria Illes Balears (IdISBa)
Organization: Multicentric
Clinical trial: No
Topic call: Diagnostics
COV20/00943 Instituto de Investigación Sanitaria Illes Balears (IdISBa) No Multicentric Diagnostics
Observational multicenter registry of patients with SARS-COV-2 infection in Spanish UCIPs (SECIP-COVID)
Rafael González Cortes
Instituto de Investigación Sanitaria Gregorio Marañón (IISGM)
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/00944 Instituto de Investigación Sanitaria Gregorio Marañón (IISGM) No Multicentric COVID-19 disease characterization
EMCOVID-19: Multiple Sclerosis and COVID-19.
Luís Brieva Ruiz
Instituto Inv. Biomédica de Lleida. Fundación Dr. Pifarre (IRBLLEIDA)
Organization: Unicentric
Clinical trial: No
Topic call: COVID-19 disease characterization, Therapies, SARS-CoV-2 characterization
COV20/00948 Instituto Inv. Biomédica de Lleida. Fundación Dr. Pifarre (IRBLLEIDA) No Unicentric COVID-19 disease characterization, Therapies, SARS-CoV-2 characterization
Naïve T lymphocyte levels as a predictor of the efficacy of the immune response against SARS-CoV-2 and its potential vaccines
Rebeca Alonso Arias
Fundación para la Investigación e Innovación Biosanitaria en el Principado de Asturias (FINBA)
Organization: Unicentric
Clinical trial: No
Topic call: Therapies
COV20/00968 Fundación para la Investigación e Innovación Biosanitaria en el Principado de Asturias (FINBA) No Unicentric Therapies
Impact of the COVID-19 pandemic on the mental health of workers in health devices. International multicenter study: The COVID-19 HEROES study
María Fe Bravo Ortiz
Fundación de Investigación Biomédica del Hospital La Paz (IdiPAZ)
Organization: Multicentric
Clinical trial: No
Topic call: Socio-economic impact
COV20/00988 Fundación de Investigación Biomédica del Hospital La Paz (IdiPAZ) No Multicentric Socio-economic impact
Disruption of viral transport processes mediated by microtubules
José Fernando Díaz Pereira
Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC)
Organization: Unicentric
Clinical trial: No
Topic call: Therapies
COV20/01007 Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC) No Unicentric Therapies
Determination of phenotypes predictive of complications in COVID-19 and evaluation of the efficacy of immunosuppressive treatments
Jesús Rodríguez Baño
Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (Fisevi)
Organization: Unicentric
Clinical trial: No
Topic call: COVID-19 disease characterization, Therapies
COV20/01031 Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (Fisevi) No Unicentric COVID-19 disease characterization, Therapies
SARS-COV-2 diagnosis by phi29 polymerase amplification
Felipe Cortés Ledesma / Luis Blanco Dávila
Centro Nacional de Investigaciones Oncológicas Carlos III (CNIO)
Organization: Unicentric
Clinical trial: No
Topic call: Diagnostics
COV20/01036 Centro Nacional de Investigaciones Oncológicas Carlos III (CNIO) No Unicentric Diagnostics
Safety of Breastfeeding (BF) in SARS-COV-2 (COVID-19) Confirmed Infection
Adelina Pellicer Martínez
Fundación de Investigación Biomédica del Hospital La Paz (IdiPAZ)
Organization: Multicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/01046 Fundación de Investigación Biomédica del Hospital La Paz (IdiPAZ) No Multicentric Epidemiological surveillance
Study of contamination of surfaces and personal protective equipment by patients with severe respiratory infection by coronavirus 2 (SARS-CoV-2) of symptomatic patients treated
Oriol Roca
Fundación del Instituto de Investigación Sanitaria Vall d'Hebron (VHIR)
Organization: Multicentric
Clinical trial: No
Topic call: Therapies
COV20/01054 Fundación del Instituto de Investigación Sanitaria Vall d'Hebron (VHIR) No Multicentric Therapies
Simulation and evaluation of the transmission dynamics of the SARS-CoV-2 virus in Spain
Óscar Gálvez González
Universidad Nacional de Educación a Distancia (UNED)
Organization: Multicentric
Clinical trial: No
Topic call: Epidemiological surveillance, Artificial intelligence
COV20/01081 Universidad Nacional de Educación a Distancia (UNED) No Multicentric Epidemiological surveillance, Artificial intelligence
CoviNanoVax: Design of a mRNA vaccine based on polymeric nanoparticles targeting dendritic cells.
Salvador Borrós/ Cristina Fornaguera
Universidad Ramón Llull (URL)
Organization: Unicentric
Clinical trial: No
Topic call: Vaccines
COV20/01100 Universidad Ramón Llull (URL) No Unicentric Vaccines
Clinical trial for the Prevention of Coronavirus Infection in Healthcare professionals (EPICOS)
Julia del Amo Valer
Fundación Estatal, Salud, Infancia y Bienestar Social, F.S.P. (fcsai)
Organization: Multicentric
Clinical trial: Yes
Topic call: Therapies
COV20/01112 Fundación Estatal, Salud, Infancia y Bienestar Social, F.S.P. (fcsai) Yes Multicentric Therapies
Registry of patients with inflammatory and autoimmune diseases with SARS-CoV2 infection.
Ricardo Blanco Alonso / Miguel Ángel González-Gay
Instituto de Investigación Sanitaria Marqués de Valdecilla (IDIVAL)
Organization: Unicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/01138 Instituto de Investigación Sanitaria Marqués de Valdecilla (IDIVAL) No Unicentric Epidemiological surveillance
Changes in lung function tests in patients with CoVid-9 pneumonia
Jaime Signes-Costa Miñana
Fundación del Hospital Clínico Universitario de Valencia (INCLIVA)
Organization: Unicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/01209 Fundación del Hospital Clínico Universitario de Valencia (INCLIVA) No Unicentric COVID-19 disease characterization
Mathematical modeling and prediction of incidence of COVID-19 outbreaks in Europe
Manuel de la Sen
Universidad del País Vasco
Organization: Unicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/01213 Universidad del País Vasco No Unicentric Epidemiological surveillance
Structural analysis of SARS-CoV-2 membrane proteins for the design of new inhibitors of viral assembly
Marcial Vilar
Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC)
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization, Therapies
COV20/01265 Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC) No Multicentric COVID-19 disease characterization, Therapies
Dynamic calculation of the SARS-CoV-2 capsid for destruction by resonance (VirionBreak)
Fermín Luis Navarrina Martínez
Universidad de la Coruña (UC)
Organization: Multicentric
Clinical trial: No
Topic call: Therapies
COV20/01275 Universidad de la Coruña (UC) No Multicentric Therapies
Th1 / Th2 / Th17 / Treg response and TLRs / KIR receptors in clinical evolution of COVID19
Alejandro Vallejo Tiller
Fundación de Investigación Biomédica del Hospital Ramón y Cajal (IRYCIS)
Organization: Unicentric
Clinical trial: No
Topic call: Epidemiological surveillance
COV20/01304 Fundación de Investigación Biomédica del Hospital Ramón y Cajal (IRYCIS) No Unicentric Epidemiological surveillance
Congenital immunity errors and predisposition to SARS-Cov-2 infection and COVID-19 severity. International coordinated action of complete exomic sequencing
Rebeca Pérez de Diego
Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/01333 Instituto de Investigación Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid No Multicentric COVID-19 disease characterization
Congenital immunity errors and predisposition to SARS-Cov-2 infection and COVID-19 severity. International coordinated action of complete exomic sequencing
José Carlos Rodríguez Gallego
Fundación del Instituto de Investigación Sanitaria de Canarias (FIISC)
Organization: Multicentric
Clinical trial: No
Topic call: COVID-19 disease characterization
COV20/01334 Fundación del Instituto de Investigación Sanitaria de Canarias (FIISC) No Multicentric COVID-19 disease characterization

This website uses cookies, and the limited processing of your personal data to function.
By using the site you are agreeing to this as outlined in our Privacy Notice.

Back to top